Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
CEO: James Boyle. Company website
Medline Inc. (MDLN) trades at $31.64, down 1.49% on the day, as of Sep 20, 2026 14:57 UTC.
Medline Inc. has a market capitalisation of $26.75B, calculated from the live MDLN share price and shares outstanding.
MDLN trades at a trailing P/E of 36.79, from earnings per share of $0.86 over the last twelve months.
Medline Inc. generated revenue of $29.94B over the trailing twelve months, which puts the stock at 0.89 times sales.
MDLN has traded between $31.49 and $50.88 over the past 52 weeks, and the last price is 37.8% below that high.
Yes. Medline Inc. keeps 2.31% of revenue as net income over the trailing twelve months.
Wall Street analysts rate MDLN Buy, with an average price target of $44.50, 40.6% above the current price.
Medline Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
James Boyle is the chief executive of Medline Inc., which employs 45,000 people.
QFI Terminal shows MDLN with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open MDLN in Terminal See plans